Prescription Drug Affordability Board: Surveys Reopened

Cosentyx & Stelara Surveys Reopened

The Prescription Drug Affordability Board (PDAB) is currently undergoing affordability reviews to determine if Cosentyx and/or Stelara are unaffordable for Colorado consumers. As part of the affordability review, the PDAB is seeking input from patients and caregivers, and individuals with scientific or medical training in the form of a short survey. Surveys aim to help the PDAB understand personal or professional experiences with Cosentyx and Stelara and will remain open until April 30, 2024.

Patients and Caregivers are encouraged to fill out the linked survey below:

• Cosentyx & Stelara: Patients and Caregivers Survey

Individuals with scientific or medical training are encouraged to fill out the linked survey below:

• Cosentyx & Stelara: Individuals with Scientific or Medical Training Survey

Upcoming Meetings

The next PDAB meeting will be held on April 26 at 10 am MT. 

Register for April 26 PDAB Meeting

Stay Connected

Stakeholders are encouraged to visit the website regularly to stay informed of all upcoming meetings. To receive PDAB and PDAAC updates directly in your inbox, click here. To subscribe, you will need to enter your email and then choose Updates From Divisions > Division of Insurance > Division of Insurance Prescription Drug Affordability Board.

Please do not reply to this email as your response will not be read or forwarded.

Subscriber Services:

Manage Subscriber Preferences |  Help